These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6392091)

  • 41. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY; Ng SY; Teo L; Koh Y; Teok CH
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Action of a combination of norsulfazole and polymyxin M on the fatty acid makeup of Pr. mirabilis].
    Lukach IG; Vasiurenko ZP
    Antibiotiki; 1978 Oct; 23(10):934-40. PubMed ID: 213013
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies of antibiotic resistance of rough and smooth Proteus mirabilis strains and influence of polymyxin E on their lipopolysaccharide composition.
    Kaca W; Ujazda E
    Acta Microbiol Pol; 1996; 45(2):161-8. PubMed ID: 8997693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [R factors in Proteus rettgeri strains].
    Toni M; Somenzi P; Montanari MP
    Ann Sclavo; 1978; 20(2):180-90. PubMed ID: 742932
    [No Abstract]   [Full Text] [Related]  

  • 45. [Sensitivity of various species of Proteus to antimicrobial drugs].
    Cellini L; Borrelli G; Piccolomini R
    G Ital Chemioter; 1983; 30(2-3):85-90. PubMed ID: 6677547
    [No Abstract]   [Full Text] [Related]  

  • 46. Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001.
    Boutiba-Ben Boubaker I; Ghozzi R; Ben Abdallah H; Mamlouk K; Kamoun A; Ben Redjeb S
    Clin Microbiol Infect; 2004 Jul; 10(7):665-7. PubMed ID: 15214883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
    Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrastructural changes produced in Proteus vulgaris by a synergistic combination of colistin and sulphadiazine.
    Handley PS; Quesnel LB; Sturgiss MM
    Microbios; 1974 May; 10(40):211-23. PubMed ID: 4369409
    [No Abstract]   [Full Text] [Related]  

  • 49. Resistotyping of Proteus mirabilis and a comparison with other methods of typing.
    Kashbur IM; George RH; Ayliffe GA
    J Clin Pathol; 1974 Jul; 27(7):572-7. PubMed ID: 4138833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasmid-mediated, inducible AmpC beta-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis.
    Yong D; Lim Y; Song W; Choi YS; Park DY; Lee H; Yum JH; Lee K; Kim JM; Chong Y
    Diagn Microbiol Infect Dis; 2005 Sep; 53(1):65-70. PubMed ID: 15936167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman.
    Potron A; Poirel L; Elhag K; Al Yaqoubi F; Nordmann P
    Int J Antimicrob Agents; 2009 Nov; 34(5):493-4. PubMed ID: 19525094
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effects of cephalothin, gentamicin, and their combination on the bacterium Proteus mirabilis].
    Lode H; Dalhoff A; Naumann P
    Int J Clin Pharmacol; 1972 Nov; 6(4):346-53. PubMed ID: 4565835
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative in vitro antibacterial activities of cefetamet (Ro 15-8074/005), a new oral cephalosporin, and eight other oral antimicrobials.
    Rozgonyi F; Papp-Falusi E; Varga J; Rozgonyi-Szitha K
    J Chemother; 1989 Jul; 1(4 Suppl):119-22. PubMed ID: 16312332
    [No Abstract]   [Full Text] [Related]  

  • 55. Emergence of Imipenem Resistance in a CpxA-H208P-Variant-Producing
    Lecuru M; Nicolas-Chanoine MH; Tanaka S; Montravers P; Armand-Lefevre L; Denamur E; Mammeri H
    Microb Drug Resist; 2021 Jun; 27(6):747-751. PubMed ID: 33232636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.
    Fernández A; Gil E; Cartelle M; Pérez A; Beceiro A; Mallo S; Tomás MM; Pérez-Llarena FJ; Villanueva R; Bou G
    J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. R-factor in Proteus vulgaris from ulcerative disease of fish, Channa punctatus.
    Mandal S; Mandal M; Pal NK; Halder PK; Basu PS
    Indian J Exp Biol; 2002 May; 40(5):614-6. PubMed ID: 12622213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noncorrelation of lipid composition with antibiotic resistance in two genuses of Enterobacteriaecae.
    Haque H; Naqvi WA
    Indian J Biochem Biophys; 1979 Feb; 16(1):40-2. PubMed ID: 385485
    [No Abstract]   [Full Text] [Related]  

  • 59. [In vitro sensitivity and in vivo resistance of some microbial strains in resuscitation].
    Fava E; Ferrotti A; Picciaiuola E
    G Ital Chemioter; 1969; 16(1):38-49. PubMed ID: 5404125
    [No Abstract]   [Full Text] [Related]  

  • 60. First description of DHA-1 ampCbeta-lactamase in Proteus mirabilis.
    Bidet P; Verdet C; Gautier V; Bingen E; Arlet G
    Clin Microbiol Infect; 2005 Jul; 11(7):591-2. PubMed ID: 15966982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.